{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:30:35Z","timestamp":1783006235378,"version":"3.54.5"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,10]]},"abstract":"<jats:p>Malignant hyperthermia (MH) is a life-threatening syndrome caused by sudden, uncontrolled skeletal muscle hypermetabolism in response to inhalation anesthetics and depolarizing relaxants. The estimated incidence of MH is between 1:10,000 and 1:250,000 anesthetic procedures. In Poland, due to lack of reporting, the incidence of MH is unknown. Dantrolene is imported as a life-saving drug (target import) and temporally authorized for sale. The aim of the study was to evaluate the prevalence of malignant hyperthermia in Poland and to assess the accessibility to dantrolene in Poland. A questionnaire was conducted among the chiefs of anesthesia and intensive care units in Poland. During the years 2014 to 2019, 10 episodes of MH have been reported in 238 surveyed polish anesthesia departments. The estimated prevalence is 1:350,000. Eight patients survived the MH crisis. Dantrolene is stocked in 48 (20%) anesthesiology departments. Among the surveyed hospitals, only in 38 (16%) it is possible to administer dantrolene within 5 minutes of suspecting a MH reaction. Less than half units (44%) have an algorithm for the management of MH episode in the operating theaters. The results of the study revealed, that the prevalence of MH in Poland is lower than the prevalence reported in other countries. Access to dantrolene in Poland is limited.<\/jats:p>","DOI":"10.1097\/md.0000000000033238","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T17:01:39Z","timestamp":1678467699000},"page":"e33238","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Malignant hyperthermia in Poland: A survey study"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0819-4885","authenticated-orcid":false,"given":"Agnieszka","family":"Cieniewicz","sequence":"first","affiliation":[{"name":"1st Department of Anesthesiology and Intensive Care, Medical University of Warsaw, Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Trzebicki","sequence":"additional","affiliation":[{"name":"1st Department of Anesthesiology and Intensive Care, Medical University of Warsaw, Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-015-0310-1","article-title":"Malignant hyperthermia: a review.","volume":"10","author":"Rosenberg","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"R2-20250504","first-page":"700","article-title":"Incidence of malignant hyperthermia in Denmark.","volume":"64","author":"Ording","year":"1985","journal-title":"Anesth Analg"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/ALN.0b013e318200197d","article-title":"Prevalence of malignant hyperthermia and relationship with anesthetics in Japan: data from the diagnosis procedure combination database [published correction appears in anesthesiology. 2011 May;114 (5):1257].","volume":"114","author":"Sumitani","year":"2011","journal-title":"Anesthesiology"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1213\/ane.0b013e3181ac1548","article-title":"Prevalence of malignant hyperthermia due to anesthesia in New York State, 2001-2005.","volume":"109","author":"Brady","year":"2009","journal-title":"Anesth Analg"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/ALN.0b013e318167aee2","article-title":"Cardiac arrests and deaths associated with malignant hyperthermia in North America from 1987 to 2006: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.","volume":"108","author":"Larach","year":"2008","journal-title":"Anesthesiology"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5114\/ait.2022.115348","article-title":"Malignant hyperthermia in Mazovia Province \u2013 are we adequately prepared?","volume":"54","author":"Cieniewicz","year":"2022","journal-title":"Anaesthesiol Intensive Ther"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF03004694","article-title":"Malignant hyperthermia: a statistical review.","volume":"17","author":"Britt","year":"1970","journal-title":"Can Anaesth Soc J"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bja.2020.04.089","article-title":"Availability of dantrolene for the management of malignant hyperthermia crises: European malignant hyperthermia group guidelines.","volume":"125","author":"Glahn","year":"2020","journal-title":"Br J Anaesth"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1213\/ANE.0b013e3181c6b9b2","article-title":"Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.","volume":"110","author":"Larach","year":"2010","journal-title":"Anesth Analg"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1213\/ANE.0b013e3182937d8b","article-title":"Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.","volume":"118","author":"Riazi","year":"2014","journal-title":"Anesth Analg"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/EJA.0b013e32833b1adf","article-title":"The Helsinki declaration on patient safety in anaesthesiology.","volume":"27","author":"Mellin-Olsen","year":"2010","journal-title":"Eur J Anaesthesiol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1213\/ANE.0b013e318298867a","article-title":"Implementing emergency manuals: can cognitive aids help translate best practices for patient care during acute events?","volume":"117","author":"Goldhaber-Fiebert","year":"2013","journal-title":"Anesth Analg"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/0163278713496425","article-title":"Enhancing surveys of health care professionals: a meta-analysis of techniques to improve response.","volume":"36","author":"Cho","year":"2013","journal-title":"Eval Health Prof"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:48:13Z","timestamp":1746326893000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033238","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,10]]}}}